Legacy Citation Support
42 U.S.C. § 1320f-4
This citation is not available as a current section page in the published edition on this site, but the citation remains a meaningful historical or legacy reference.
Use the current title page and nearby sections below to continue browsing Title 42. When old citations remain in crawlers, briefs, or legacy links, this page preserves the citation locally instead of sending users to a dead end.
Nearby current sections
- § 1320e–1 — Limitations on certain uses of comparative clinical effectiveness research
- § 1320e–2 — Trust Fund transfers to Patient-Centered Outcomes Research Trust Fund
- § 1320e–3 — Information exchange with payroll data providers
- § 1320f — Establishment of program
- § 1320f–1 — Selection of negotiation-eligible drugs as selected drugs
- § 1320f–2 — Manufacturer agreements
- § 1320f–3 — Negotiation and renegotiation process
- § 1320f–4 — Publication of maximum fair prices